This is a long stock. We don't know what they have plans to put out in the next few months. Long term target still remains: $.0485+. I got in with 3.5 million shares and not looking to triple it anytime soon but looking for 10x return investment within a year which is predictable now that the company is starting to ship to Brazil. Mexico seems next. 2-3 containers shipping to Brazil could generate $400k to $600k a month and over $6 million in revenues plus domestic sales are increasing and will continue to increase with 100 salesman are being hire across the country. One year from now, the company could literally be generating over $10 million a year in revenues. Given the market will be willing to give 10 to 20 times the credit of revenues, the market cap should be sitting at over $150 million. So even if they max out on authorize shares of 1.8 billion which I doubt they would max it out in a year, PPS should be sitting at $.08s or $.09s by holiday 2015. I don't buy in stocks for over night growth, I buy stocks that will give me 5 to 10 times my original investment. So far I've been right with picking the right companies. Good luck to everybody here.
This is a long stock. We don't know what they have plans to
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Arch Painting Champions Community Support at Major Event
Arch Painting's Commitment to Community Support Arch Painting, a prominent entity in paint contracting services, is taking significant steps to support community initiatives. Recently, the company made headlines by becoming a Gold Sponsor of the Mobility Awareness Resource Community (M.A.R.C.) Network during a high-profile football event. The sponsorship highlights Arch...
Continue Reading
Radioligand Therapy Market Growth Forecast to $10.9 Billion
Radioligand Therapy Market Growth and Future Outlook The global Radioligand Therapy (RLT) market is witnessing promising growth, with expectations to reach a valuation of USD 10.91 billion by the early 2030s, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2025 onward. This significant progression can be attributed to the increasing number of approvals and...
Continue Reading
Boston Scientific Achieves Remarkable Growth in 2024 Earnings
Introduction to Boston Scientific's 2024 Financial Triumph Boston Scientific Corporation (NYSE: BSX) has announced impressive results for the fourth quarter and the entire year of 2024. The figures indicate robust growth in net sales and earnings, underscoring the company's strong position in the medical technology sector. During the fourth quarter, net sales reached a...
Continue Reading
Top Tech Stocks to Watch: Momentum Indicators to Note
Key Technology Stocks Exhibiting Momentum The information technology sector continues to capture the attention of investors, particularly those who prioritize momentum as a vital part of their trading strategies. In the rapidly evolving landscape of tech stocks, three companies have recently emerged as noteworthy players due to significant momentum indicators that may...
Continue Reading
Autoliv Exceeds Expectations as Key Stocks Surge on Friday
Autoliv Reports Strong Third-Quarter Results On a recently mixed trading day for U.S. stocks, significant gains were noted with the Nasdaq Composite surging approximately 100 points. Among the noteworthy performers, shares of Autoliv, Inc. exhibited an impressive increase following the company’s announcement concerning its third-quarter financial performance. Key...
Continue Reading